KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Neogenomics (NEO) Tax Provisions (2016 - 2025)

Neogenomics (NEO) has disclosed Tax Provisions for 13 consecutive years, with -$2.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Tax Provisions fell 214.05% year-over-year to -$2.5 million, compared with a TTM value of -$2.2 million through Dec 2025, down 15.08%, and an annual FY2025 reading of -$2.2 million, down 15.08% over the prior year.
  • Tax Provisions was -$2.5 million for Q4 2025 at Neogenomics, down from $740000.0 in the prior quarter.
  • Across five years, Tax Provisions topped out at $976000.0 in Q1 2021 and bottomed at -$5.7 million in Q2 2022.
  • Average Tax Provisions over 5 years is -$1.8 million, with a median of -$2.4 million recorded in 2021.
  • The sharpest move saw Tax Provisions crashed 742.39% in 2021, then soared 593.33% in 2025.
  • Year by year, Tax Provisions stood at -$2.4 million in 2021, then dropped by 16.03% to -$2.8 million in 2022, then surged by 66.16% to -$960000.0 in 2023, then grew by 16.25% to -$804000.0 in 2024, then plummeted by 214.05% to -$2.5 million in 2025.
  • Business Quant data shows Tax Provisions for NEO at -$2.5 million in Q4 2025, $740000.0 in Q3 2025, and -$724000.0 in Q2 2025.